These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 2680437)

  • 21. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroduodenal problems associated with non-steroidal, anti-inflammatory drugs (NSAIDs).
    Hawkey CJ
    Scand J Gastroenterol Suppl; 1993; 200():94-5. PubMed ID: 8016579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.
    Hudson N; Taha AS; Russell RI; Trye P; Cottrell J; Mann SG; Swanell AJ; Sturrock RD; Hawkey CJ
    Gastroenterology; 1997 Jun; 112(6):1817-22. PubMed ID: 9178671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A
    Br J Hosp Med; 1993 Jun 2-15; 49(11):767-72. PubMed ID: 8101464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healing and prevention of NSAID-induced peptic ulcers.
    Hawkey CJ
    Scand J Gastroenterol Suppl; 1994; 201():42-4. PubMed ID: 8047823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
    Singh G; Triadafilopoulos G
    Int J Clin Pract; 2005 Oct; 59(10):1210-7. PubMed ID: 16178990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal effects of NSAIDs. Difficulties in detection and management.
    Pearson SP; Kelberman I
    Postgrad Med; 1996 Nov; 100(5):131-2, 135-6, 141-3. PubMed ID: 8917329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery in the management of the gastric side-effects of NSAIDs.
    Venables CW
    Aliment Pharmacol Ther; 1988; 2 Suppl 1():97-111. PubMed ID: 2979288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acid-NSAID/aspirin interaction in peptic ulcer disease.
    Hunt RH; Yuan Y
    Dig Dis; 2011; 29(5):465-8. PubMed ID: 22095011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper gastro-intestinal disease in Scotland: a survey of practice amongst Scottish gastroenterologists.
    Kubba AK; Whyman MR
    J R Coll Surg Edinb; 1996 Oct; 41(5):302-6. PubMed ID: 8908952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of nonsteroidal anti-inflammatory drug-associated gastric and duodenal damage. Efficacy of antisecretory drugs and mucosal protective compounds.
    Pipkin G; Mills JG
    Dig Dis; 1995 Jan; 13 Suppl 1():75-88. PubMed ID: 7697904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.